BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 4427813)

  • 1. An in vitro collodion-lipid membrane model for drug absorption studies.
    Brandys J; Kwiek J; Witek J
    Pol J Pharmacol Pharm; 1974; 26(5):519-26. PubMed ID: 4427813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilicity and biological acitivity. Drug transport and drug distribution in model systems and in biological systems.
    Kubinyi H
    Arzneimittelforschung; 1979; 29(8):1067-80. PubMed ID: 40579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
    Falk M; Fürst W
    Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
    Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
    Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of complex formation on drug absorption. VI. Drug permeation through an artificial lipoid barrier.
    Levy G; Mroszczak EJ
    J Pharm Sci; 1968 Feb; 57(2):235-9. PubMed ID: 5641664
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of lipids on the permeation of substances through lipid collodium membranes].
    Falk M
    Pharmazie; 1987 Apr; 42(4):276-7. PubMed ID: 3615566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intestinal absorption of drugs].
    Antonioli JA
    Rev Med Suisse Romande; 1969 Sep; 89(9):873-81. PubMed ID: 5398163
    [No Abstract]   [Full Text] [Related]  

  • 9. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug permeation through synthetic lipid membranes. Permeability of lecithin-collodium membranes for drugs and metabolites].
    Falk M; Fürst W
    Pharmazie; 1974 Sep; 29(9):590-3. PubMed ID: 4420510
    [No Abstract]   [Full Text] [Related]  

  • 11. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contributions to the liberation of drugs from suspension ointments. Part 12: On the suitability of some synthetic hydrophobic membranes for liberation studies (author's transl)].
    Horsch W; Fürst W; Zerbe A; Finke I; Winter K; Richter H
    Pharmazie; 1981; 36(1):24-8. PubMed ID: 7220582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
    Fürst W; Neubert R; Richter H; Reppel L
    Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay.
    Velkov T; Horne J; Laguerre A; Jones E; Scanlon MJ; Porter CJ
    Chem Biol; 2007 Apr; 14(4):453-65. PubMed ID: 17462580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorption studies with purines. Part 1: In vitro experiments with the Sartorius Absorption Model according to Stricker].
    Heppt-Becker I; Schunack W
    Arzneimittelforschung; 1976; 26(3):317-21. PubMed ID: 989319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)].
    Fürst W; Neubert R; Förster B; Reppel L
    Pharmazie; 1980; 34(5-6):315-6. PubMed ID: 7413708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug permeability through artificial lipoid membranes. 1. Preparation of lecithin membranes].
    Fürst W; Falk M
    Pharmazie; 1970 Sep; 25(9):546-50. PubMed ID: 5486683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.